|Blogs||Articles||Organizations||Biography||Jack's Book||Contact Information||Links|
Navigation: SOS Sisson > Traumatic Injury Blog
Jack Sisson's TBI Blog
A hug is duct tape for the soul.
Sunday, November 25, 2012
Citicoline Supplement Doesn't Help Treat Brain Injury, Study Finds
From U.S. News and World Report:
The 'nutraceutical' had been widely used to ease trauma damage, but research shows no effect
The supplement citicoline does nothing to help improve brain function in patients with traumatic brain injury, a new study finds.
In the United States, citicoline is widely available at health food stores as a nutraceutical -- a product that reportedly provides health and medical benefits -- and is used by patients with a range of neurologic disorders.
Citicoline is also approved for treatment of traumatic brain injury, but such use had not been evaluated in a large, randomized clinical trial, noted Dr. Ross Zafonte, of Harvard Medical School, Spaulding Rehabilitation and Massachusetts General Hospital in Boston, and colleagues.
Their phase 3 clinical trial included more than 1,200 patients with mild, moderate or severe brain injuries. The patients started taking either citicoline or an inactive placebo within 24 hours of their injury and continued the therapy for 90 days.
Brain function tests conducted after the treatment period showed little difference between the two groups of patients. Rates of improvement ranged from about 35 percent to 86 percent in the citicoline group, similar to 36 percent to 84 percent observed in the placebo group.
A second evaluation, conducted six months after the brain injury, again revealed little difference between patients who took citicoline and those who took the placebo, according to the study published in the Nov. 21 issue of the Journal of the American Medical Association.
One expert said the study findings are disheartening.
The lack of any therapeutic effect "is another disappointment for individuals with traumatic brain injury," said Wayne Gordon, vice chair of the department of rehabilitation medicine at the Mount Sinai School of Medicine in New York City. He said "it highlights the fact that traumatic brain injury as an injury is not 'one-size-fits-all' and research is needed to develop approaches to the better classification of brain injury."
The study authors agreed, saying their findings suggest that the "worldwide use of citicoline for traumatic brain injury should now be questioned."
Dr. Danny Liang is a neurosurgeon at the Cushing Neuroscience Institute, part of the North Shore-LIJ Health System, in Manhasset, N.Y. He said that the new study "gives the medical community the most objective way to evaluate this potential therapy."
However, "this was a well-designed study that unfortunately gave disappointing results," Liang said.
The U.S. National Institute of Neurological Disorders and Stroke has more about traumatic brain injury.
Link to U.S. News and World Report.
LinksTBI Film Reviews
TBI Book Reviews
Traumatic Brain Injury Law Blog
SoapBlox/Chicago: Protecting Our Troops
Head Injury Survival Journal
Losing the Physical Self
Tower of Hanoi: Instructions for this popular puzzle can be viewed simply by clicking the Instructions button on that page.
May 2005 June 2005 July 2005 August 2005 September 2005 October 2005 November 2005 August 2006 September 2006 October 2006 December 2006 January 2007 February 2007 March 2007 April 2007 May 2007 June 2007 July 2007 August 2007 September 2007 October 2007 November 2007 December 2007 January 2008 February 2008 March 2008 January 2009 March 2009 April 2009 December 2009 April 2010 May 2010 June 2010 July 2010 August 2010 September 2010 October 2010 November 2010 January 2011 February 2011 March 2011 April 2011 May 2011 June 2011 July 2011 August 2011 September 2011 October 2011 November 2011 December 2011 January 2012 February 2012 March 2012 April 2012 May 2012 June 2012 October 2012 November 2012 December 2012 January 2013 February 2013 March 2013 April 2013 May 2013 June 2013 October 2013